Request for Information (RFI): Innovative Therapeutic Approaches for Phelan-McDermid Syndrome

We are calling academic investigators and biotechnology companies developing therapeutics for neurodevelopmental diseases to submit innovative therapeutic concepts that could be advanced toward clinical development for PMS. Submissions will inform future CureSHANK strategy, including potential funding calls and partnerships, and will enable infrastructure development.

The full announcement and additional information can be found here.

Responses are due by Feb 15, 2026. Inqueries can be submitted to CureShank's Chief Science Officer Ralf Schmid at rfi@cureshank.org.